A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102
NCT00048217
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
T-1249
Sponsor
Trimeris